Autoimmunity and Immune-Dysregulation in Hematological Diseases
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".
Deadline for manuscript submissions: closed (15 August 2023) | Viewed by 3203
Special Issue Editors
Interests: cryptococcus neoformans; transgenic mice; platelet transfusion; apheresis; genetics; platelets; antibodies; cells; blood; hematopoiesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Immunological diseases require prompt recognition and testing using diagnostic algorithms that minimize the possibility of long-term sequelae and/or complications. These autoimmune diseases can be experienced due to the generation of cell-mediated or antibody-mediated responses to self-antigens in most tissue systems. Indeed, the formation of autoantibodies mediating pathological presentations in a myriad of diseases requiring initiation and, in many cases, maintenance of chronic immunosuppression exemplifies some of the challenges facing clinicians across disciplines. Hematological diseases caused by formation of such autoantibodies can present with anemia, thrombocytopenia, and hypercoagulability among other features that, depending on the targeted antigen, require specific therapeutics to be initiated. Furthermore, autoimmune diseases have been associated with an elevated risk of developing hematological malignancies, particularly lymphoproliferative tumors.
Thus, the goal of this Special Issue is to examine autoimmunity in hematological disease processes mediated by autoantibody formation and/or immune cell dysfunction. Original submissions describing new developments in the pathophysiology, diagnosis, and therapeutics of hematological diseases with autoimmune components are encouraged. Submissions describing current insights regarding underlying pathophysiological mechanisms, new biologicals or new ways of using existing agents, and reviews are also welcome. Case reports will be considered if the description involves significant novel findings to merit publication or if they include a thorough review of the covered topic.
Dr. Robert Maitta
Dr. Xiangrong He
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmunity
- hematological
- autoantibody
- T cell
- immune dysregulation
